Frontlight ResearchEarly access
Diabetic eye disease trials in Argentina
3 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
- Where
- CABA, Mendoza, Quilmes
- Age
- 18 years and over
- People
- 960 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07705555 · EU 2026-526790-42-01 - Phase 3Taking peopleA Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)
- Where
- CABA, Córdoba
- Age
- 18 years and over
- People
- 1,104 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07705607 · EU 2026-526787-20-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTO
- Where
- Caba, Comodoro Rivadavia, Mendoza, Rosario
- Age
- 18 years and over
- People
- 910 worldwide
- Run by
- Kodiak Sciences Inc
See details and how to joinNCT07734844